Man Group’s ClearPoint Neuro CLPT Stock Holding History

Man Group’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$213K	Buy	+11,950	New	+$149K	﹤0.01%	2258
2026 Q1	–	Sell	-10,520	Closed	-$144K	–	2419
2025 Q4	$144K	Sell	10,520 -17,950	-63%	-$333K	﹤0.01%	2163
2025 Q3	$620K	Sell	28,470 -43,414	-60%	-$511K	﹤0.01%	1803
2025 Q2	$858K	Buy	71,884 +10,674	+17%	+$134K	﹤0.01%	1667
2025 Q1	$728K	Sell	61,210 -10,777	-15%	-$168K	﹤0.01%	1670
2024 Q4	$1.11M	Buy	+71,987	New	+$932K	﹤0.01%	1461
2023 Q1	–	Sell	-15,124	Closed	-$132K	–	1924
2022 Q4	$128K	Buy	+15,124	New	+$143K	﹤0.01%	1867
2022 Q2	–	Sell	-24,007	Closed	-$250K	–	2099
2022 Q1	$250K	Buy	+24,007	New	+$219K	﹤0.01%	1840

Other funds holding CLPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

CFM

Compass Financial Management Tampa, Florida $829M AUM

Man Group's CLPT Position: Q2 2026 in Review

Man Group opened a new position in ClearPoint Neuro (CLPT) in Q2 2026: 11,950 shares worth $213K. The stake represents ﹤0.01% of the portfolio and ranks #2258 among its holdings. This is a return to the name: Man Group previously reported a position in CLPT as recently as Q4 2025.

Man Group first reported a position in CLPT in Q1 2022 and has held it in 8 quarters since. The position peaked at $1.11M in Q4 2024. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

Man Group held 11,950 shares of ClearPoint Neuro worth $213K as of Q2 2026.
ClearPoint Neuro was a new Man Group position in Q2 2026.
ClearPoint Neuro made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2258 holding.
Man Group first reported a position in ClearPoint Neuro in Q1 2022 and has held it in 8 quarters since.
Man Group's ClearPoint Neuro position peaked at $1.11M in Q4 2024.
129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.